Deeper understandings of the implications of altered expressions of MEIS1, AGTR1, BAK1, DTL and TYMS, call for detailed clinical studies for further insights into HNSCC pathogenesis. This evidence concerns the gene MEIS1 and head and neck squamous cell carcinoma.